Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ELANE | P08246 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12918623 | 1.00 | HTT (0.59) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL11411338 | 0.95 | HTT (0.54) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL3285794 | 0.95 | HTT (0.54) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL24605352 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL27947111 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL12370833 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL2741099 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL13135270 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL13135348 | 0.93 | KMT2A (0.68) | HTTKMT2ASMN1; SMN2TDP1ELANE | |
| SCHEMBL10040441 | 0.91 | KMT2A (0.50) | HTTKMT2ASMN1; SMN2TDP1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230037751-A1 | OPTICALLY ANISOTROPIC LAYER, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-3307797-B1 | ALIGNMENT POLYMERS | TRANSITIONS OPTICAL INC (US) | 2021-10-20 | — | — | EP | disclosed |
| US-11130912-B2 | Alignment polymers | TRANSITIONS OPTICAL, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| US-10883048-B2 | Polymerizable composition including polymerizable liquid crystal compound, film, and method of manufacturing film | FUJIFILM CORPORATION (JP) | 2021-01-05 | — | — | US | disclosed |
| US-10875833-B2 | Alignment compounds | TRANSITIONS OPTICAL, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| EP-3307798-B1 | ALIGNMENT COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2020-08-05 | — | — | EP | disclosed |
| US-10619098-B2 | Ultraviolet light absorbers | TRANSITIONS OPTICAL, INC. (US) | 2020-04-14 | — | — | US | disclosed |
| EP-3201292-B1 | ULTRAVIOLET LIGHT ABSORBERS | TRANSITIONS OPTICAL INC (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2957949-B1 | LIQUID CRYSTAL DISPLAY DEVICE | DAINIPPON INK & CHEMICALS (JP) | 2018-07-18 | — | — | EP | disclosed |
| US-20180179445-A1 | POLYMERIZABLE COMPOSITION INCLUDING POLYMERIZABLE LIQUID CRYSTAL COMPOUND, FILM, AND METHOD OF MANUFACTURING FILM | FUJIFILM CORPORATION (JP) | 2018-06-28 | — | — | US | disclosed |
| US-20080199782-A1 | Hologram recording material, hologram recording medium and hologram recording method | FUJI XEROX CO., LTD. (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080167482-A1 | mesogenic group is linked to the C-atom No. 5 of the 1,3-dioxane-5-yl group; media showing a blue phase and their use in electro-optical light modulation elements | MERCK PATENT GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080116419-A1 | Mesogenic Compounds, Liquid Crystal Medium and Liquid Crystal Display | MERCK PATENT GMBH (DE) | 2008-05-22 | — | — | US | disclosed |
| US-7335404-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7294368-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-11-13 | — | — | US | disclosed |
| US-7258903-B2 | Fast switching liquid crystal compositions for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-20070176144-A1 | Liquid crystal composition for bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2007-08-02 | — | — | US | disclosed |
| US-20070080325-A1 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7195719-B1 | High polarization ferroelectric liquid crystal compositions | DISPLAYTECH, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-7195719-B1 | High polarization ferroelectric liquid crystal compositions | DISPLAYTECH, INC. (US) | 2007-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10619098-B2 | Ultraviolet light absorbers | ERCC1, MCM4, ERCC4 | HTT 337/4885KMT2A 2831/4885SMN1; SMN2 3802/4885 |
| US-10875833-B2 | Alignment compounds | CYP19A1, ESR1, CCNE2 | HTT 1936/4885KMT2A 724/4885SMN1; SMN2 2912/4885 |
| US-20080116419-A1 | Mesogenic Compounds, Liquid Crystal Medium and Liquid Crystal Display | CRY1, CRY2, IK | HTT 3406/4885KMT2A 2914/4885SMN1; SMN2 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.